Zika virus-like particles (VLPs): Stable cell lines and continuous perfusion processes as a new potential vaccine manufacturing platform.

Saved in:
Bibliographic Details
Title: Zika virus-like particles (VLPs): Stable cell lines and continuous perfusion processes as a new potential vaccine manufacturing platform.
Authors: Alvim RGF; Federal University of Rio de Janeiro (UFRJ), COPPE, Cell Culture Engineering Lab, Cx. Postal 68502, 21941-972 Rio de Janeiro/RJ, Brazil; Federal University of Rio de Janeiro (UFRJ), School of Chemistry (EQ), Department of Biochemical Engineering, 21941-909 Rio de Janeiro/RJ, Brazil., Itabaiana I Jr; Federal University of Rio de Janeiro (UFRJ), School of Chemistry (EQ), Department of Biochemical Engineering, 21941-909 Rio de Janeiro/RJ, Brazil., Castilho LR; Federal University of Rio de Janeiro (UFRJ), COPPE, Cell Culture Engineering Lab, Cx. Postal 68502, 21941-972 Rio de Janeiro/RJ, Brazil. Electronic address: leda@peq.coppe.ufrj.br.
Source: Vaccine [Vaccine] 2019 Nov 08; Vol. 37 (47), pp. 6970-6977. Date of Electronic Publication: 2019 Jun 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2019.05.064